Collaboration Between Team Gleason and Synchron Expands BCI Efforts
Synchron, a leading brain-computer interface (BCI) company, and Team Gleason, a foundation focused on enhancing the lives of individuals living with Amyotrophic Lateral Sclerosis (ALS), have expanded their partnership to promote awareness of the Synchron BCI Community. This collaboration underscores their mutual goal of empowering individuals with paralysis and advancing cutting-edge solutions for mobility and independence.
“Thecollaboration of our partnership with Team Gleason will help us extend the reach of the BCI Community and bring greater awareness to this groundbreaking technology,” said Tom Oxley, M.D., CEO and Founder of Synchron. “Together, we can offer more people the chance to participate in the development of neuroprosthetics and BCI technology, and we are thrilled about the potential of this collaboration.”
The Synchron BCI Community is an initiative created to connect people with disabilities, their caregivers, and clinicians. Its purpose is to educate members about how BCI technology is being designed to give autonomy to those with limited mobility. Additionally, it provides a platform to keep interested parties informed about upcoming clinical trial opportunities. A key aspect of the initiative is Team Gleason’s role in fostering engagement and encouraging enrollment in the program.
Team Gleason will play an active part in raising awareness by sharing updates and information through various channels such as newsletters, support groups, and social media. These efforts aim to educate both people with ALS and their caregivers on the importance of accelerating the development of life-changing assistive technologies like Synchron’s BCI.
Blair Casey, Executive Director of Team Gleason, shared, “The BCI Community initiative offers a remarkable opportunity for individuals living with ALS to shape the future of assistive technology. By collaborating with Synchron, we are ensuring that the voices of people living with neurological conditions are heard and that innovations meet their specific needs.”
The Synchron BCI is an advanced neuroprosthetic device that works by being implanted into the blood vessels on the surface of the motor cortex of the brain. This procedure is minimally invasive and is done via the jugular vein. Once implanted, the device detects and wirelessly transmits motor intent from the brain, helping individuals with severe paralysis control personal devices hands-free. This technology offers a lifeline for people with limited mobility, restoring their ability to interact with the digital world.
For more details on the Synchron BCI and its registry, visit https://synchronbci.com.
The Synchron BCI Community is an ongoing effort to advance the development of the company’s endovascular brain-computer interface by gathering insights from individuals who have paralysis or severe motor impairments. This initiative also serves as an opportunity for individuals to learn more about upcoming clinical trials. Synchron’s goal is to create a platform that facilitates collaboration between patients and developers to accelerate the technology’s adoption.
Team Gleason, founded by former New Orleans Saints player Steve Gleason, provides vital resources to people living with ALS. Since its inception in 2011, Team Gleason has been committed to improving life for ALS patients by providing cutting-edge technology, equipment, and empowering individuals to continue leading meaningful lives. The foundation’s mission focuses on enhancing the life experience of people with ALS, ensuring they remain productive and engaged.
Synchron, a clinical-stage neurotechnology company, is at the forefront of developing brain-computer interfaces to help those with severe paralysis regain autonomy. Their innovative endovascular BCI neuroprosthesis aims to restore motor signaling and help individuals control devices, restoring functionality for those with motor impairments. Synchron is headquartered in New York City, and its work is groundbreaking in the field of assistive technology.
This expanded partnership between Synchron and Team Gleason holds significant promise for advancing both the development of life-changing technology and the involvement of ALS patients in the creation of solutions that are tailored to their needs. Together, they are pushing the boundaries of innovation in the BCI space and creating a future where more individuals living with neurological conditions can regain independence and improve their quality of life.
Please find the related post
